Nitrilase mediated mild hydrolysis of a carbon‐14 nitrile for the radiosynthesis of 4‐(7‐hydroxycarbamoyl‐[1‐ 14 C‐heptanoyl]‐oxy)‐benzoic acid methyl ester, [ 14 C]‐SHP‐141: A novel class I/II histone deacetylase (HDAC) inhibitor
Journal of Labelled Compounds and Radiopharmaceuticals · 2023
DOI: 10.1002/jlcr.4026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2023. Verfasst von Sean L Kitson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology, Almac, 20 Seagoe Industrial Estate, Craigavon, UK. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Benzoic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
A strategy has been developed for the carbon‐14 radiosynthesis of [ 14 C]‐SHP‐141 , a 4‐(7‐hydroxycarbamoyl‐heptanoyloxy)‐benzoic acid methyl ester derivative containing a terminal hydroxamic acid. The synthesis involved four radiochemical transformations. The key step in the radiosynthesis was the conversion of the 7‐[ 14 C]‐cyano‐heptanoic acid benzyloxyamide [ 14 C]‐4 directly into the carboxylic acid derivative, 7‐benzyloxycarbamoyl‐[ 14 C]‐heptanoic acid [ 14 C]‐8 using nitrilase‐113 biocatalyst. The final step involved deprotection of the benzyloxy group using catalytic hydrogenation to facilitate the release of the hydroxamic acid without cleaving the phenoxy ester. [ 14 C]‐SHP‐141 was isolated with a radiochemical purity of 90% and a specific activity of 190 μCi/mg from four radiochemical steps starting from potassium [ 14 C]‐cyanide in a radiochemical yield of 45%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Technology, Almac, 20 Seagoe Industrial Estate, Craigavon, UK.
- Arran Chemical Company Limited, Unit 1 Monksland Industrial Estate, Athlone, Co, Roscommon, Ireland.
- Shape Pharmaceuticals Inc, Cambridge, MA, USA.
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Harvard T.H. Chan School of Public Health, Boston, MA, USA.
ORCID-Profile: Sean L Kitson
Zitieren
APA
Kitson, S. L., Watters, W., Moody, T. S., Chappell, T., & Mazitschek, R. (2023). Nitrilase mediated mild hydrolysis of a carbon‐14 nitrile for the radiosynthesis of 4‐(7‐hydroxycarbamoyl‐[1‐ 14 C‐heptanoyl]‐oxy)‐benzoic acid methyl ester, [ 14 C]‐SHP‐141: A novel class I/II histone deacetylase (HDAC) inhibitor. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4026
Vancouver
Kitson SL, Watters W, Moody TS, Chappell T, Mazitschek R. Nitrilase mediated mild hydrolysis of a carbon‐14 nitrile for the radiosynthesis of 4‐(7‐hydroxycarbamoyl‐[1‐ 14 C‐heptanoyl]‐oxy)‐benzoic acid methyl ester, [ 14 C]‐SHP‐141: A novel class I/II histone deacetylase (HDAC) inhibitor. Journal of Labelled Compounds and Radiopharmaceuticals. 2023. doi:10.1002/jlcr.4026
BibTeX
@article{Kitson2023,
author = {Kitson, Sean L and Watters, William and Moody, Thomas S and Chappell, Todd and Mazitschek, Ralph},
title = {Nitrilase mediated mild hydrolysis of a carbon‐14 nitrile for the radiosynthesis of 4‐(7‐hydroxycarbamoyl‐[1‐ 14 C‐heptanoyl]‐oxy)‐benzoic acid methyl ester, [ 14 C]‐SHP‐141: A novel class I/II histone deacetylase (HDAC) inhibitor},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2023},
doi = {10.1002/jlcr.4026}
}
EUVIMED